MedTrace Logo

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

NCT07321899 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1186

Last updated 2026-01-08

No results posted yet for this study

Summary

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

Conditions

  • Severe Tricuspid Regurgitation

Interventions

DEVICE

Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System

Transcatheter Tricuspid Valve Replacement

DEVICE

Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System

Transcatheter Tricuspid Valve Replacement

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Vinayak N. Bapat, MD · Minneapolis Heart Institute

  • Anita Asgar, MD · Northwestern Medicine Bluhm Cardiovascular Institute

  • Nicolas Dumonteil, MD · Clinique Pasteur Groupe CardioVasculaire Interventionnel

  • Azeem Latib, MD · Montefiore Medical Center

  • Firas Zahr, MD · Knight Cardiovascular Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2031-09-30
Completion
2041-04-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07321899 on ClinicalTrials.gov